PubMed

Preserved Inhibitory Potency of GLP-1 on Glucagon Secretion in Type 2 Diabetes Mellitus.

Hare KJ, Knop FK, Asmar M, Madsbad S, Deacon CF, Holst JJ, Vilsbøll T.

J Clin Endocrinol Metab. 2009 Oct 16. [Epub ahead of print]PMID: 19837930 [PubMed - as supplied by publisher]Related articles

The spectrum of antidiabetic actions of GLP-1 in patients with diabetes.

Vilsbøll T, Holst JJ, Knop FK.

Best Pract Res Clin Endocrinol Metab. 2009 Aug;23(4):453-62.PMID: 19748063 [PubMed - in process]Related articles

Resolution of type 2 diabetes following gastric bypass surgery: involvement of gut-derived glucagon and glucagonotropic signalling?

Knop FK.

Diabetologia. 2009 Sep 1. [Epub ahead of print]PMID: 19727661 [PubMed - as supplied by publisher]Related articles

Lixisenatide, a novel GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus.

Christensen M, Knop FK, Holst JJ, Vilsboll T.

IDrugs. 2009 Aug;12(8):503-13. Review.PMID: 19629885 [PubMed - indexed for MEDLINE]Related articles

Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists.

Hansen KB, Knop FK, Holst JJ, Vilsbøll T.

Int J Clin Pract. 2009 Aug;63(8):1154-60.PMID: 19624785 [PubMed - in process]Related articles

Incretin-based therapy of type 2 diabetes mellitus.

Knop FK, Vilsbøll T, Holst JJ.

Curr Protein Pept Sci. 2009 Feb;10(1):46-55. Review.PMID: 19275672 [PubMed - indexed for MEDLINE]Related articles

KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

Aaboe K, Knop FK, Vilsboll T, Vølund A, Simonsen U, Deacon CF, Madsbad S, Holst JJ, Krarup T.

J Clin Endocrinol Metab. 2009 Feb;94(2):603-8. Epub 2008 Dec 2.PMID: 19050053 [PubMed - indexed for MEDLINE]Related articles

Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes.

Højberg PV, Vilsbøll T, Zander M, Knop FK, Krarup T, Vølund A, Holst JJ, Madsbad S.

Diabet Med. 2008 Nov;25(11):1268-75.PMID: 19046215 [PubMed - indexed for MEDLINE]Related articles

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.

Højberg PV, Vilsbøll T, Rabøl R, Knop FK, Bache M, Krarup T, Holst JJ, Madsbad S.

Diabetologia. 2009 Feb;52(2):199-207. Epub 2008 Nov 27.PMID: 19037628 [PubMed - indexed for MEDLINE]Related articles

Long-acting GLP-1 analogs for the treatment of type 2 diabetes mellitus.

Vilsbøll T, Knop FK.

BioDrugs. 2008;22(4):251-7. Review.PMID: 18611067 [PubMed - indexed for MEDLINE]Related articles

Replacing SUs with incretin-based therapies for type 2 diabetes mellitus: challenges and feasibility.

Knop FK, Holst JJ, Vilsbøll T.

IDrugs. 2008 Jul;11(7):497-501. Review.PMID: 18600596 [PubMed - indexed for MEDLINE]Related articles

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.

Højberg PV, Zander M, Vilsbøll T, Knop FK, Krarup T, Vølund A, Holst JJ, Madsbad S.

Diabetologia. 2008 Apr;51(4):632-40. Epub 2008 Feb 22.PMID: 18292985 [PubMed - indexed for MEDLINE]Related articles

The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.

Knop FK, Vilsbøll T, Højberg PV, Larsen S, Madsbad S, Holst JJ, Krarup T.

Regul Pept. 2007 Dec 4;144(1-3):123-30. Epub 2007 Jul 13.PMID: 17692937 [PubMed - indexed for MEDLINE]Related articles

[Effect of incretin hormones GIP and GLP-1 for the pathogenesis of type 2 diabetes mellitus]

Vilsbøll T, Knop FK.

Ugeskr Laeger. 2007 May 28;169(22):2101-5. Review. Danish. PMID: 17553392 [PubMed - indexed for MEDLINE]Related articles

[GLP-1-based treatment of type 2 diabetes mellitus]

Knop FK, Vilsbøll T.

Ugeskr Laeger. 2007 May 28;169(22):2095-9. Review. Danish. PMID: 17553390 [PubMed - indexed for MEDLINE]Related articles

Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state?

Knop FK, Vilsbøll T, Højberg PV, Larsen S, Madsbad S, Vølund A, Holst JJ, Krarup T.

Diabetes. 2007 Aug;56(8):1951-9. Epub 2007 May 18.PMID: 17513701 [PubMed - indexed for MEDLINE]Related articlesFree article

Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.

Knop FK, Vilsbøll T, Madsbad S, Holst JJ, Krarup T.

Diabetologia. 2007 Apr;50(4):797-805. Epub 2007 Jan 16.PMID: 17225124 [PubMed - indexed for MEDLINE]Related articles

Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution.

Knop FK, Vilsbøll T, Larsen S, Højberg PV, Vølund A, Madsbad S, Holst JJ, Krarup T.

Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E324-30. Epub 2006 Sep 5.PMID: 16954337 [PubMed - indexed for MEDLINE]Related articlesFree article

[The benefits of diagnostic imaging in general practice]

Knop FK, Stauning JA.

Ugeskr Laeger. 2006 Feb 20;168(8):794-8. Danish. PMID: 16499845 [PubMed - indexed for MEDLINE]Related articles

The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells.

Schisler JC, Jensen PB, Taylor DG, Becker TC, Knop FK, Takekawa S, German M, Weir GC, Lu D, Mirmira RG, Newgard CB.

Proc Natl Acad Sci U S A. 2005 May 17;102(20):7297-302. Epub 2005 May 9.PMID: 15883383 [PubMed - indexed for MEDLINE]Related articlesFree article

Delayed ischemic cecal perforation despite optimal decompression after placement of a self-expanding metal stent: report of a case.

Knop FK, Pilsgaard B, Meisner S, Wille-Jørgensen P.

Dis Colon Rectum. 2004 Nov;47(11):1970-3.PMID: 15622593 [PubMed - indexed for MEDLINE]Related articles

Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center.

Meisner S, Hensler M, Knop FK, West F, Wille-Jørgensen P.

Dis Colon Rectum. 2004 Apr;47(4):444-50. Epub 2004 Mar 4.PMID: 14994110 [PubMed - indexed for MEDLINE]Related articles

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.

Vilsbøll T, Knop FK, Krarup T, Johansen A, Madsbad S, Larsen S, Hansen T, Pedersen O, Holst JJ.

J Clin Endocrinol Metab. 2003 Oct;88(10):4897-903.PMID: 14557471 [PubMed - indexed for MEDLINE]Related articlesFree article

No hypoglycemia after subcutaneous administration of glucagon-like peptide-1 in lean type 2 diabetic patients and in patients with diabetes secondary to chronic pancreatitis.

Knop FK, Vilsbøll T, Larsen S, Madsbad S, Holst JJ, Krarup T.

Diabetes Care. 2003 Sep;26(9):2581-7.PMID: 12941722 [PubMed - indexed for MEDLINE]Related articlesFree article

Small-bowel hemangiosarcoma and capsule endoscopy.

Knop FK, Hansen MB, Meisner S.

Endoscopy. 2003 Jul;35(7):637. No abstract available. PMID: 12822111 [PubMed - indexed for MEDLINE]Related articles